- Home
- CAPT vs PLUR Comparison
CAPT vs PLUR Comparison
Compare CAPT & PLUR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CAPT
- PLUR
- Stock Information
- Founded
- CAPT 2005
- PLUR 2001
- Country
- CAPT South Korea
- PLUR Israel
- Employees
- CAPT N/A
- PLUR N/A
- Industry
- CAPT Blank Checks
- PLUR Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- CAPT Finance
- PLUR Health Care
- Exchange
- CAPT Nasdaq
- PLUR Nasdaq
- Market Cap
- CAPT 31.2M
- PLUR 36.9M
- IPO Year
- CAPT N/A
- PLUR N/A
- Fundamental
- Price
- CAPT $0.83
- PLUR $4.01
- Analyst Decision
- CAPT
- PLUR Strong Buy
- Analyst Count
- CAPT 0
- PLUR 1
- Target Price
- CAPT N/A
- PLUR $12.00
- AVG Volume (30 Days)
- CAPT 154.6K
- PLUR 9.4K
- Earning Date
- CAPT 01-01-0001
- PLUR 11-11-2025
- Dividend Yield
- CAPT N/A
- PLUR N/A
- EPS Growth
- CAPT N/A
- PLUR N/A
- EPS
- CAPT N/A
- PLUR N/A
- Revenue
- CAPT $17,389,944.00
- PLUR $1,336,000.00
- Revenue This Year
- CAPT N/A
- PLUR $97.38
- Revenue Next Year
- CAPT N/A
- PLUR $293.97
- P/E Ratio
- CAPT N/A
- PLUR N/A
- Revenue Growth
- CAPT 84.70
- PLUR 309.82
- 52 Week Low
- CAPT $0.37
- PLUR $3.33
- 52 Week High
- CAPT $1.94
- PLUR $7.13
- Technical
- Relative Strength Index (RSI)
- CAPT 39.02
- PLUR 37.63
- Support Level
- CAPT $0.82
- PLUR $4.20
- Resistance Level
- CAPT $0.86
- PLUR $4.35
- Average True Range (ATR)
- CAPT 0.05
- PLUR 0.23
- MACD
- CAPT 0.00
- PLUR -0.03
- Stochastic Oscillator
- CAPT 10.25
- PLUR 22.47
About CAPT Captivision Inc.
Captivision Inc Formerly Glaam Co Ltd is engaged in manufacturing, installing, and selling LED display G-Glass. G-Glass is an integrated ICT product that has the basic characteristics of transparent glass but can display media images at the same time. It implements media images through the glass surface while preserving the features of clear and transparent glass. G-Glass is the world's first IT building material that can be applied to various places where glass is used.
About PLUR Pluri Inc.
Pluri Inc is a biotechnology company engaged in the research, development, and manufacturing of cell-based products, as well as the commercialization of cell therapeutics and related technologies aimed at delivering solutions across a range of industries, including regenerative medicine, immunotherapy, food tech, CDMO, and AgTech. The company uses its 3D cell expansion technology platform to develop placenta-based cell therapy product candidates (PLX-PAD and PLX-R18) for the treatment of inflammatory, muscle injuries, and hematologic conditions. In addition, it offers CDMO services through PluriCDMO, has launched a novel immunotherapy platform, and is engaged in developing cultivated, cell-cultured coffee and meat.